Do telemedicine and digital health interventions improve clinical outcomes such as central obesity and glycemic control in patients with metabolic syndrome?
Telemedicine and digital health interventions are effective, scalable adjuncts for managing metabolic syndrome, specifically improving central obesity and glycemic control.
Telemedicine and digital health interventions represent effective adjuncts to conventional lifestyle management of MetS, particularly for central obesity and glycemic outcomes. Their ability to deliver scalable, personalized, and remotely supported care highlights their potential role in cardiometabolic prevention and management. Further research is needed to standardize intervention components and optimize long-term effectiveness.
Bertini et al. (Tue,) studied this question.